Primary Record
Retigabine
- In stock
- 1,744 g
- Purity
- 99.6 %
- CAS
- 150812-12-7
Compound Identifiers & Properties
- CAS
- 150812-12-7
- PubChem CID
- 121892
- SMILES
- CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N
- Canonical SMILES
- CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N
Names & Synonyms
- Retigabine
- Ezogabine
- Potiga
- Trobalt
- 150812-12-7
- Retigabina
- Potiva
- retigabinum
- Retigabin
- Ezogabine [USAN]
- Retigabine?
- Retigabine [USAN]
- Retigabine [INN]
- Retigabine Dihydrochloride
- Retigabine (INN)
- Ezogabine (USAN)
- Potiga (TN)
- GKE-841
- D-23129
- EZOGABINE [MI]
- AC1L3TLD
- RefChem:139807
- 12G01I6BBU
- EZOGABINE [VANDF]
- UNII-12G01I6BBU
- XEN496
- WAY-143841
- Retigabine-d4 Dihydrochloride
- C16H18FN3O2
- CHEMBL41355
- D0X7GL
- RETIGABINE [MART.]
- XEN-496
- RETIGABINE [WHO-DD]
- AWD-21360
- AWD21-360
- GW582892X
- SCHEMBL20835
- cc-439
- CHEBI:68584
- HSDB 8171
- orb146123
- GW-582892X
- RETIGABINE [EMA EPAR]
- DTXSID40164615
- GKI 841
- N03AX21
- Retigabine, analytical standard
- GTPL2601
- DEA No. 2779
- EZOGABINE [ORANGE BOOK]
- DTXCID5087106
- GW 582892X
- Retigabine, >=98% (HPLC)
- SCHEMBL29359156
- WAY 143841
- CTK8E8130
- ZINC16154
- Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate
- PCOBBVZJEWWZFR-UHFFFAOYSA-N
- GLXC-05007
- HMS3748I09
- HMS3885L20
- HMS5083I22
- Retigabine (1.0 mg/mL in Acetonitrile)
- ADD-230001
- AMY18466
- BCP04194
- EX-A2203
- KBC88670
- KE-0201
- KS-000007VJ
- Retigabine,D2312, D-23129
- BDBM50143558
- C16-H18-F-N3-O2
- CID121892
- KE 841
- MFCD04307735
- N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
- s4733
- ZINC00016154
- ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
- AKOS015895311
- D 20443
- D 23129
- D-20443
- Retigabine Dihydrochloride Impurity 17
- AC-6908
- AN-6616
- CCG-267503
- CS-0990
- CS-O-02282
- DB04953
- FA61501
- QC-1587
- RL01925
- NCGC00346739-01
- NCGC00346739-05
- NCGC00346739-06
- AJ-08384
- AW21-360
- BC210476
- HY-15471
- LS-48932
- SC-23393
- ZB000739
- BCP0726000089
- AB0035830
- ethyl (2-amino-4-((4-fluorobenzyl)amino)phenyl)carbamate
- J751.646K
- N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester
- RT-015392
- 2632B
- AE3 - Newer Anti-epileptic drug mixtures 3
- B5888
- Ethyl (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)carbamate
- NS00040686
- RetigabineSee also: R189051 (HCl salt)
- TL80090034
- Y0237
- A11922
- C13826
- D09569
- D23129
- Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate
- ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate
- S-7700
- 812R127
- A809076
- 2-AMINO-4-(4-FLUORBENZYLAMINO)-1-ETHOXYCARBONYLAMINOBENZENE
- Carbamic acid, (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)-, ethyl ester
- ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
- I06-0810
- Q2146170
- [2-Amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-carbamate
- BRD-K89917372-001-01-2
- ethyl 2-amino-4-(4-fluorobenzylamino)phenylcarbamate
- 150812-13-8
- N-(2-amino-4-[fluorobenzylamino]-phenyl) carbamic acid|D-23129
- ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride
- ethyl N-(2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate
- (1R,3S)-3-(tert-Butoxycarbonylamino)cyclohexanecarboxylic Acid
- 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene
- Ethyl (2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate
- ethyl N-(2-amino-4-((4-fluorophenyl)methylamino)phenyl)carbamate
- N-(2-amino-4-(4-fluorobenzylamino)-phenyl)carbamic acid ethylester
- n-[2-amino-4-(4-fluorobenzylamino)-phenyl]carbamic acid ethyl ester
- n-[2-amino-4-(4-fluorobenzylamino)phenyl]carbamic acid ethyl ester
- [2-Amino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester
- 1285886-70-5
- N-[2-Amino-4-[(4-fluorobenzyl)amino]phenyl]carbamic acid ethyl ester
- N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamic acid ethyl ester
- RTG
- 1,1,2,2,2-pentadeuterioethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
- CARBAMIC ACID, (2-AMINO-4-(((4-FLUORO-PHENYL)METHYL)AMINO)PHENYL)-ETHYL ESTER
- N-[2-Amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamic acid ethyl ester
- Carbamic acid, N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester; Carbamic acid, [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester (9CI); D 23129; Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate; Ezogabine; GKE 841; GW 582892X; Potiga; Retigabine; Trobalt; WAY 143841; GW 582892X; Ezogabine
- EZG
- FBX
- Retigabine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material